Saito Y, Kobayashi Y. Contemporary coronary drug-eluting and coated stents: an updated mini-review (2023). Cardiovasc Interv Ther. 2023;39:15–7.

Article  PubMed  Google Scholar 

Natsuaki M, Sonoda S, Yoshioka G, Hongo H, Kaneko T, Kashiyama K, et al. Antiplatelet therapy after percutaneous coronary intervention: current status and future perspectives. Cardiovasc Interv Ther. 2022;37:255–63.

Article  PubMed  Google Scholar 

Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364:226–35.

Article  CAS  PubMed  Google Scholar 

Erlinge D, Maehara A, Ben-Yehuda O, Bøtker HE, Maeng M, Kjøller-Hansen L, et al. Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study. Lancet. 2021;397:985–95.

Article  CAS  PubMed  Google Scholar 

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, et al. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015;372:2387–97.

Article  CAS  PubMed  Google Scholar 

Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376:1713–22.

Article  CAS  PubMed  Google Scholar 

Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, et al. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med. 2018;379:2097–107.

Article  CAS  PubMed  Google Scholar 

Tsujita K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Yamanaga K, et al. Impact of dual lipid-lowering strategy with ezetimibe and atorvastatin on coronary plaque regression in patients with percutaneous coronary intervention: The multicenter randomized controlled PRECISE-IVUS trial. J Am Coll Cardiol. 2015;66:495–507.

Article  PubMed  Google Scholar 

Nicholls SJ, Puri R, Anderson T, Ballantyne CM, Cho L, Kastelein JJP, et al. Effect of evolocumab on progression of coronary disease in statin-treated patients: The GLAGOV randomized clinical trial. JAMA. 2016;316:2373–84.

Article  CAS  PubMed  Google Scholar 

Räber L, Ueki Y, Otsuka T, Losdat S, Häner JD, Lonborg J, et al. Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction: The PACMAN-AMI randomized clinical trial. JAMA. 2022;327:1771–81.

Article  PubMed  PubMed Central  Google Scholar 

Nicholls SJ, Kataoka Y, Nissen SE, Prati F, Windecker S, Puri R, et al. Effect of evolocumab on coronary plaque phenotype and burden in statin-treated patients following myocardial infarction. JACC Cardiovasc Imaging. 2022;15:1308–21.

Article  PubMed  Google Scholar 

Koskinas KC, Windecker S, Pedrazzini G, Mueller C, Cook S, Matter CM, et al. Evolocumab for early reduction of ldl cholesterol levels in patients with acute coronary syndromes (EVOPACS). J Am Coll Cardiol. 2019;74:2452–62.

Article  CAS  PubMed  Google Scholar 

Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 2023;00:1–107.

Google Scholar 

Waksman R, Di Mario C, Torguson R, Ali ZA, Singh V, Skinner WH, et al. Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study. Lancet. 2019;394:1629–37.

Article  CAS  PubMed  Google Scholar 

Xing L, Higuma T, Wang Z, Aguirre AD, Mizuno K, Takano M, et al. Clinical significance of lipid-rich plaque detected by optical coherence tomography: a 4-year follow-up study. J Am Coll Cardiol. 2017;69:2502–13.

Article  PubMed  Google Scholar 

Prati F, Romagnoli E, Gatto L, La MA, Burzotta F, Ozaki Y, et al. Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: The CLIMA study. Eur Heart J. 2020;41:383–91.

Article  PubMed  Google Scholar 

Kubo T, Ino Y, Mintz GS, Shiono Y, Shimamura K, Takahata M, et al. Optical coherence tomography detection of vulnerable plaques at high risk of developing acute coronary syndrome. Eur Hear Journal Cardiovasc Imaging. 2021;22:1376–84.

Google Scholar 

Uemura S, Ishigami KI, Soeda T, Okayama S, Sung JH, Nakagawa H, et al. Thin-cap fibroatheroma and microchannel findings in optical coherence tomography correlate with subsequent progression of coronary atheromatous plaques. Eur Heart J. 2012;33:78–85.

Article  PubMed  Google Scholar 

Fujiyoshi K, Minami Y, Ishida K, Kato A, Katsura A, Muramatsu Y, et al. Incidence, factors, and clinical significance of cholesterol crystals in coronary plaque: An optical coherence tomography study. Atherosclerosis. 2019;283:79–84.

Article  CAS  PubMed  Google Scholar 

Abdelwahed YS, Nelles G, Frick C, Seppelt C, Meteva D, Stähli BE, et al. Coexistence of calcified- and lipid-containing plaque components and their association with incidental rupture points in acute coronary syndrome-causing culprit lesions: results from the prospective OPTICO-ACS study. Eur Hear J Cardiovasc Imaging. 2022;23:1598–605.

Article  Google Scholar 

Kato K, Yonetsu T, Kim SJ, Xing L, Lee H, McNulty I, et al. Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes a 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging. 2012;5:433–40.

Article  PubMed  Google Scholar 

Kubo T, Imanishi T, Kashiwagi M, Ikejima H, Tsujioka H, Kuroi A, et al. Multiple coronary lesion instability in patients with acute myocardial infarction as determined by optical coherence tomography. Am J Cardiol. 2010;105:318–22.

Article  PubMed  Google Scholar 

Hong M-K, Mintz GS, Lee CW, Lee J-W, Park J-H, Park D-W, et al. A three-vessel virtual histology intravascular ultrasound analysis of frequency and distribution of thin-cap fibroatheromas in patients with acute coronary syndrome or stable angina pectoris. Am J Cardiol. 2008;101:568–72.

Article  PubMed  Google Scholar 

Ando H, Amano T, Matsubara T, Uetani T, Nanki M, Marui N, et al. Comparison of tissue characteristics between acute coronary syndrome and stable angina pectoris: An integrated backscatter intravascular ultrasound analysis of culprit and non-culprit lesions. Circ J. 2011;75:383–90.

Article  PubMed  Google Scholar 

Vergallo R, Uemura S, Soeda T, Minami Y, Cho JM, Ong DS, et al. Prevalence and Predictors of Multiple Coronary Plaque Ruptures: In Vivo 3-Vessel Optical Coherence Tomography Imaging Study. Arterioscler Thromb Vasc Biol. 2016;36:2229–2238.

Baber U, Stone GW, Weisz G, Moreno P, Dangas G, Maehara A, et al. Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes. JACC Cardiovasc Imaging. 2012;5:S53-61.

Article  PubMed  Google Scholar 

Kato K, Yonetsu T, Jia H, Abtahian F, Vergallo R, Hu S, et al. Nonculprit coronary plaque characteristics of chronic kidney disease. Circ Cardiovasc Imaging. 2013;6:448–56.

Article  PubMed  Google Scholar 

Minami Y, Wang Z, Aguirre AD, Ong DS, Kim CJ, Uemura S, et al. Clinical predictors for lack of favorable vascular response to statin therapy in patients with coronary artery disease: A serial optical coherence tomography study. J Am Heart Assoc. 2017;6:1–10.

Article  Google Scholar 

Marso SP, Mercado N, Maehara A, Weisz G, Mintz GS, McPherson J, et al. Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes. JACC Cardiovasc Imaging. 2012;5:S42-52.

Article  PubMed  Google Scholar 

Kato K, Yonetsu T, Kim SJ, Xing L, Lee H, McNulty I, et al. Comparison of nonculprit coronary plaque characteristics between patients with and without diabetes: A 3-vessel optical coherence tomography study. JACC Cardiovasc Interv. 2012;5:1150–8.

Article  PubMed  Google Scholar 

Kedhi E, Berta B, Roleder T, Hermanides RS, Fabris E, IJsselmuiden AJJ, et al. Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the Combine OCT-FFR trial. Eur Heart J 2021;42:4671–4679.

Kini AS, Baber U, Kovacic JC, Limaye A, Ali ZA, Sweeny J, et al. Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy). J Am Coll Cardiol. 2013;62:21–9.

Article  CAS  PubMed  Google Scholar 

Nasu K, Tsuchikane E, Katoh O, Tanaka N, Kimura M, Ehara M, et al. Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound. JACC Cardiovasc Interv. 2009;2:689–96.

Article  PubMed  Google Scholar 

Yokoyama M, Komiyama N, Courtney BK, Nakayama T, Namikawa S, Kuriyama N, et al. Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study. Am Heart J. 2005;150:287.

Article  PubMed